First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial (Q35034306)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial |
scientific article |
Statements
1 reference
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial (English)
1 reference
A Sarah Walker
1 reference
Lynne Mofenson
1 reference
Abdel Babiker
1 reference
Gareth Tudor-Williams
1 reference
Carlo Giaquinto
1 reference
Alexandra Compagnucci
1 reference
Lynda Harper
1 reference
Susan Fiscus
1 reference
PENPACT-1 (PENTA 9/PACTG 390) Study Team
1 reference
Hannah Castro nee Green
1 reference
Linda Harrison
1 reference
Michael Hughes
1 reference
Ross McKinney
1 reference
Ann Melvin
1 reference
Yacine Saidi
1 reference
M Elizabeth Smith
1 reference
31 January 2011
1 reference
1 reference
11
1 reference
4
1 reference
273-283
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference